Filing Details
- Accession Number:
- 0001140361-15-037186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-10-08 16:14:40
- Reporting Period:
- 2015-10-06
- Filing Date:
- 2015-10-08
- Accepted Time:
- 2015-10-08 16:14:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1472091 | Edge Therapeutics Inc. | EDGE | Pharmaceutical Preparations (2834) | 264231384 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1492256 | J. Robert Spiegel | 200 Connell Drive, Suite 1600 Berkeley Heights NJ 07922 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-10-06 | 23,579 | $0.00 | 23,579 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2015-10-06 | 10,533 | $0.00 | 34,112 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2015-10-06 | 3,000 | $11.00 | 37,112 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2015-10-06 | 1,549 | $7.91 | 38,661 | No | 4 | J | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct | |
| No | 4 | J | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series C-1 Convertible Preferred Stock | Disposition | 2015-10-06 | 32,258 | $0.00 | 23,579 | $0.00 |
| Common Stock | Series C-2 Convertible Preferred Stock | Disposition | 2015-10-06 | 14,409 | $0.00 | 10,533 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The convertible preferred stock converted into the Issuer's common stock at a conversion ratio, as adjusted to give effect to the Issuer's 1-for-1.3681 reverse stock split effected on September 21, 2015, of one share of common stock for every 1.3681 shares of preferred stock immediately prior to the closing of the Issuer's initial public offering of common stock, and had no expiration date.
- The Reporting Person received a total of 1,549 shares of the Issuer's common stock, which represented a payment-in-kind dividend on 46,667 shares of the Issuer's convertible preferred stock owned at the time of the dividend payment date.
Billionaire Hedge Funds
